March 31, 2023 Chase C. Leavitt Oncternal Therapeutics, Inc. Dear Mr. Leavitt:Oncternal Therapeutics, Inc. • May 4th, 2023 • Pharmaceutical preparations
Company FiledMay 4th, 2023 IndustryOncternal Therapeutics, Inc. (the “Company”) is providing this letter agreement to set forth agreements between you and the Company related to your compensation. This letter agreement amends the Employment Agreement between you and the Company, dated April 12, 2021 (the “Employment Agreement”).
March 31, 2023 Rajesh Krishnan, Ph.D. Oncternal Therapeutics, Inc. Dear Dr. Krishnan:Oncternal Therapeutics, Inc. • May 4th, 2023 • Pharmaceutical preparations
Company FiledMay 4th, 2023 IndustryOncternal Therapeutics, Inc. (the “Company”) is providing this letter agreement to set forth agreements between you and the Company related to your compensation. This letter agreement amends the Amended and Restated Employment Agreement between you and the Company, dated January 6, 2021 (the “Employment Agreement”).
March 31, 2023 Gunnar Kaufmann, Ph.D. Oncternal Therapeutics, Inc. Dear Dr. Kaufmann:Oncternal Therapeutics, Inc. • May 4th, 2023 • Pharmaceutical preparations
Company FiledMay 4th, 2023 IndustryOncternal Therapeutics, Inc. (the “Company”) is providing this letter agreement to set forth agreements between you and the Company related to your compensation. This letter agreement amends the Employment Agreement between you and the Company, dated September 5, 2019 (the “Employment Agreement”).